Product Images Exemestane
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Exemestane NDC 72603-329 by Northstar Rx Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
figure-1 - exemestane fig1
This text provides statistical information about a clinical trial, including data on HR (Hazard Ratio), b(log-rank), the number of events and patients in each treatment group, and the duration of disease-free survival in months. The HR value indicates the ratio of hazards or risks between groups, while the log-rank p-value helps determine statistical significance in survival analysis. The table shows data for two treatment arms, TeamentRandomized and Tamoxifen, in terms of events, patients, and disease-free survival over time.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 25 mg (30 Tablets Bottle) - exemestane fig3
This text contains information about Exemestane tablets, with each film-coated tablet containing 25 mg of Exemestane USP. The storage instructions recommend storing the tablets at a temperature between 20°C to 25°C (68°F to 77°F). The usual dosage information is not provided, and it refers to accompanying prescribing information. The manufacturing details indicate that the tablets are manufactured for Northstar Rx LLC in Memphis, TN, with the tablets being manufactured by Eugia Pharma Specialities Limited in India. The product is labeled as a product of India. The issue date of the product is September 2024. The NDC code for the tablets is 72603-329-01, and the packaging contains 30 tablets.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.